Skip to main content

DISEÑO DE BIOMARCADORES PARA DEMENCIA FRONTO-TEMPORAL ASOCIADA A MUTACIONES EN GRN

PI19/01637

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre ASOCIACION INSTITUTO BIODONOSTIA
Execution centre HOSPITAL DONOSTIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex differences in clinical phenotypes of behavioral variant frontotemporal dementia

  • Liu, X.
  • de Boer, S.C.M.
  • Cortez, K.
  • Poos, J.M.
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Heuer, H.
  • Forsberg, L.K.
  • Casaletto, K.
  • Memel, M.|||0000-0001-6827-6335
  • Appleby, B.S.
  • Barmada, S.
  • Bozoki, A.
  • Clark, D.
  • Cobigo, Yann|||0000-0002-0354-4092
  • Darby, R.
  • Dickerson, B.C.
  • Domoto-Reilly, K.
  • Galasko, D.R.
  • Geschwind, D.H.
  • Ghoshal, N.
  • Graff-Radford, N.R.
  • Grant, I.M.
  • Hsiung, G.Y.R.
  • Honig, L.S.
  • Huey, E.D.
  • Irwin, D.
  • Kantarci, K.
  • Léger, G.C.
  • Litvan, I.
  • Mackenzie, I.R.
  • Masdeu, J.C.
  • Mendez, M.F.
  • Onyike, C.U.
  • Pascual, B.
  • Pressman, P.
  • Bayram, E.
  • Ramos, E.M.
  • Roberson, E.D.
  • Rogalski, E.
  • Bouzigues, A.
  • Russell, L.L.
  • Foster, P.H.
  • Ferry-Bolder, E.
  • Masellis, M.
  • van Swieten, J.
  • Jiskoot, L.
  • Seelaar, H.
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Laforce, Robert Jr|||0000-0002-2031-490X
  • Graff, Caroline|||0000-0002-9949-2951
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • de Mendonça, Alexandre|||0000-0002-0488-1453
  • Tiraboschi, P.
  • Santana, I.
  • Gerhard, Alexander
  • Levin, J.
  • Sorbi, Sandro|||0000-0002-0380-6670
  • Otto, Markus
  • Pasquier, Florence|||0000-0001-9880-9788
  • Ducharme, S.
  • Butler, C.R.
  • Ber, I.L.
  • Finger, E.
  • Rowe, J.B.
  • Synofzik, M.
  • Moreno, F.
  • Borroni, Barbara|||0000-0001-9340-9814
  • Boeve, Bradley
  • Boxer, A.L.
  • Rosen, H.J.
  • Pijnenburg, Y.A.L.
  • Rohrer, Jonathan D.
  • Tartaglia, M.C.
INTRODUCTION: Higher male prevalence in sporadic behavioral variant frontotemporal dementia (bvFTD) has been reported. We hypothesized differences in phenotypes between genetic and sporadic bvFTD females resulting in underdiagnosis of sporadic bvFTD females. METHODS: We included genetic and sporadic bvFTD patients from two multicenter cohorts. We compared behavioral and cognitive symptoms, and gray matter volumes, between genetic and sporadic cases in each sex. RESULTS: Females with sporadic bvFTD showed worse compulsive behavior (p = 0.026) and language impairments (p = 0.024) compared to females with genetic bvFTD (n = 152). Genetic bvFTD females had smaller gray matter volumes than sporadic bvFTD females, particularly in the parietal lobe. DISCUSSION: Females with sporadic bvFTD exhibit a distinct clinical phenotype compared to females with genetic bvFTD. This difference may explain the discrepancy in prevalence between genetic and sporadic cases, as some females without genetic mutations may be misdiagnosed due to atypical bvFTD symptom presentation. Highlights: Sex ratio is equal in genetic behavioral variant of frontotemporal dementia (bvFTD), whereas more males are present in sporadic bvFTD. Distinct neuropsychiatric phenotypes exist between sporadic and genetic bvFTD in females. Phenotype might explain the sex ratio difference between sporadic and genetic cases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Cortical microstructure is associated with disease severity and clinical progression in genetic frontotemporal dementia, a GENFI study

  • Rodriguez-Vieitez, Elena|||0000-0002-6639-8141
  • Rydell, Melissa T.
  • Ullgren, Abbe
  • Montal, Victor|||0000-0002-5714-9282
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Fortea, Juan|||0000-0002-1340-638X
  • Jelic, Vesna
  • Bouzigues, Arabella|||0000-0002-0267-8590
  • Russell, Lucy L.
  • Foster, Phoebe H.
  • Ferry-Bolder, Eve
  • van Swieten, John C.
  • Jiskoot, Lize C.
  • Seelaar, Harro|||0000-0003-1989-7527
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Laforce, Robert
  • Galimberti, Daniela|||0000-0002-9284-5953
  • Vandenberghe, Rik|||0000-0001-6237-2502
  • de Mendonça, Alexandre|||0000-0002-0488-1453
  • Tiraboschi, Pietro
  • Santana, Isabel|||0000-0002-8114-9434
  • Gerhard, Alexander
  • Levin, Johannes|||0000-0001-5092-4306
  • Sorbi, Sandro|||0000-0002-0380-6670
  • Otto, M.|||0000-0003-4273-4267
  • Pasquier, Florence|||0000-0001-9880-9788
  • Ducharme, Simon
  • Butler, Chris R.|||0000-0002-7502-9284
  • Le Ber, Isabelle|||0000-0002-2508-5181
  • Finger, Elizabeth
  • Tartaglia, Maria Carmela
  • Masellis, Mario
  • Rowe, James B.
  • Synofzik, Matthis|||0000-0002-2280-7273
  • Moreno, Fermin|||0000-0001-5200-3164
  • Borroni, Barbara|||0000-0001-9340-9814
  • Rohrer, Jonathan D.
  • Westman, Eric|||0000-0002-3115-2977
  • Graff, Caroline|||0000-0002-9949-2951
The study of genetic frontotemporal dementia (FTD) allows investigating its earliest presymptomatic stages. Using cross-sectional T1-weighted and diffusion-weighted MRI, we test the hypothesis that cortical microstructural alterations, quantified as cortical mean diffusivity (cMD), are detectable earlier and are more strongly associated with clinical progression than cortical thickness (CTh). The sample comprised n = 710 individuals (47.8 ± 13.5 years, 56.6% female, 14.1 ± 3.3 years of education), including 118 symptomatic carriers and 305 presymptomatic carriers with mutations in C9orf72, GRN or MAPT genes, and 287 non-carriers, collected from 24 GENFI sites. A subset of n = 453 individuals (289 carriers, 164 non-carriers) were investigated across Clinical Dementia Rating (CDR) = 0, 0.5 and ≥1 stages. Two subsets had longitudinal clinical outcome measures, including n = 403 individuals (239 carriers, 164 non-carriers) with Cambridge Behavioural Inventory-Revised scores during 2.8 ± 1.6 years, and n = 261 individuals (164 carriers, 97 non-carriers) with CDR Sum-of-Boxes scores during 2.0 ± 0.8 years. Regional cMD and CTh were entered into linear mixed-effects models incorporating age, sex and education as covariates; site, and individual nested within site were random intercepts. The results demonstrated that cMD is more sensitive than CTh to track early cortical injury, with elevated cMD first observed at CDR = 0 in C9orf72 carriers, followed by MAPT carriers (from CDR = 0.5 stage), and by GRN carriers (beginning at CDR ≥ 1). At all stages, cortical microstructural injury had stronger effect size and was more widespread than cortical thinning. In all mutation carrier types, cMD was more strongly associated than CTh with subsequent clinical progression. Cortical microstructure is a promising biomarker to identify at-risk individuals before atrophy and clinical progression, with utility in therapeutic trials.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Mitochondria and lipid defects in hereditary progranulin-related frontotemporal dementia

  • Ondaro, Jon
  • Zúñiga Elizari, Jose Luis
  • Zufiría García, Mónica
  • Garciandia-Arcelus, Maddi
  • Sánchez Molleda, Ángela
  • Zulaica Ijurco, Miren
  • Lafarga, Miguel
  • Riancho, Javier
  • López de Munain, Adolfo
  • Moreno, Fermin
  • Gil Bea, Francisco Javier
  • Gerenu, Gorka
Frontotemporal dementia (FTD) is a neurodegenerative disorder predominantly affecting individuals under 65 years of age, characterized by significant behavioral and language disabilities. Despite extensive research efforts, effective treatments for FTD remain elusive. Familial cases of FTD have been linked to genetic mutations in several key genes, among these, mutations in granulin (GRN) account for 5–20% of cases, leading to haploinsufficiency of progranulin (PGRN), a multifunctional glycoprotein. This study investigates the cellular pathology associated with GRN insufficiency by using fibroblasts derived from FTD patients carrying the c.709-1G>A GRN mutation (FTD-GRN). These fibroblasts exhibited pathological hallmarks of FTD, including lysosomes, autophagosomes, and lipofuscin accumulation, mirroring observations in affected patient tissues. Notably, we report mitochondrial abnormalities, characterized by mitochondrial swelling which is associated with decreased mitochondrial respiration, and lipid droplet accumulation, reflecting altered lipid metabolism. Experimental supplementation with recombinant human progranulin (rhPGRN) was associated with recovery of lysosomal acidification and attenuation of mitochondrial and lipid abnormalities in vitro. This study reveals that GRN haploinsufficiency induces mitochondrial and lipid dysfunctions, suggesting that these pathways may contribute to FTD-GRN pathogenesis and could be of interest for therapeutic development., This research was funded by Grant PID2023-153029OA-I00 funded by MICIU/AEI/10.13039/501100011033 and, as appropriate, by 'ERDF A way of making Europe', by 'ERDF/EU', by the 'European Union' or by the 'European Union NextGenerationEU/PRTR'. The Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union through the European Regional Development Fund (ERDF) (grant numbers P18/01066, PI19/01637, PI21/00153, PI24/01025); by CIBERNED-Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (grant number CB06/05/1126, Group 609); by the Diputación Foral de Gipuzkoa (project 2021-CIEN-000020-01); by EiTB Maratoia (BIO17/ND/023/BD); by Fundació La Marató (grant number 202006-32); and by the IKUR strategy of the Basque Government (NEURODEGENPROT project), as well as the Basque Government Department of Health (Eusko Jaurlaritzako Osasun Saila; grant numbers 2017222027, 2018111042, 2019222020, and 2021333050). J.O., J.L., M.Z., and M.G. received predoctoral support from the Department of Education of the Basque Government through grants PRE2018_1_0095, PRE2022_1_0315, PRE2015_1_0023, and PRE2020_1_0122, respectively. F.G. was supported by the Roche 'Stop Fuga de Cerebros' program (BIO19/ROCHE/017/BD). G.G. was funded by the Juan de la Cierva-Incorporación fellowship from the Spanish Ministry of Science and Innovation (IJC2019-039965-I). F.G., and G.G. received additional support from the IKERBASQUE Research Foundation. The APC was funded by the same funding sources, in accordance with the authors' affiliation with the University of the Basque Country (UPV/EHU).